Caris Life Sciences (CAI) Non Operating Income (2024 - 2026)

Caris Life Sciences' Non Operating Income history runs 3 years deep, the most recent figure standing at -$5.9 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 86.72% year-over-year to -$5.9 million; the TTM figure through Mar 2026 stood at -$74.5 million (down 47.25% YoY), while the FY2025 annual figure was -$113.2 million, down 357.05% from the prior year.
• Non Operating Income for Q1 2026 stood at -$5.9 million, up from -$6.5 million in the prior quarter.
• The five-year high for Non Operating Income was $825000.0 in Q2 2024, with the low at -$53.8 million in Q2 2025.
• The 3-year median for Non Operating Income is -$6.7 million (2024), against an average of -$15.6 million.
• The sharpest annual moves came in 2025 and 2026: Non Operating Income tumbled 6621.33% in 2025, then surged 86.72% in 2026.
• Caris Life Sciences' Non Operating Income stood at $99000.0 in 2024, then sank by 6619.19% to -$6.5 million in 2025, then grew by 8.18% to -$5.9 million in 2026.
• Business Quant data shows CAI's Non Operating Income at -$5.9 million in Q1 2026, -$6.5 million in Q4 2025, and -$8.3 million in Q3 2025.